05:25:49 EDT Tue 21 May 2019
Enter Symbol
or Name

Login ID:

Q:RHHBY - ROCHE HOLDINGS AG - http://roche.com05:25:49 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RHHBY - Qnot subscribed33.11+0.270.81,015.633,4662,96532.81  33.11  32.7334.98  26.30May 20 16:41:49May 1515 min RT 2¢

Recent Trades - Last 10 of 2965
Time ETExPriceChangeVolume

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2019-05-15 17:00U:RHHBYNews ReleaseGenentech ’s Personalized Medicine Entrectinib Shrank Tumors Harboring NTRK, ROS1 or ALK Gene Fusions in Children and Adolescents
2019-05-15 14:20U:RHHBYNews ReleaseGenentech Announces FDA Approval for Venclexta Plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia
2019-05-10 01:00U:RHHBYNews ReleaseGenentech to Present New Data Highlighting Comprehensive Approach to Cancer Care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
2019-05-08 01:00U:RHHBYNews ReleaseGenentech to Present New OCREVUS (Ocrelizumab) Data Analyses Showing Significant Reduction of Disability Progression in Relapsing and Primary Progressive Multiple Sclerosis at the AAN Annual Meeting
2019-05-07 01:00U:RHHBYNews ReleaseGenentech Presents Data from the Risdiplam Pivotal FIREFISH and SUNFISH Studies in Spinal Muscular Atrophy at the 2019 AAN Annual Meeting
2019-05-06 07:00U:RHHBYNews ReleaseRoche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis
2019-05-03 15:45U:RHHBYNews ReleaseFDA Approves Genentech ’s Kadcyla for Adjuvant Treatment of People with HER2-Positive Early Breast Cancer with Residual Invasive Disease After Neoadjuvant Treatment
2019-04-30 10:00U:RHHBYNews ReleaseNimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners
2019-04-29 01:00U:RHHBYNews ReleaseNew Genentech Data at the 2019 AAN Annual Meeting Showcase Breadth and Promise of Neuroscience Portfolio